Table 2.
Characteristics | New care package, n (%)* | Conventional care, n (%)* | p Value† |
---|---|---|---|
Total | 870 | 961 | |
Age in years | |||
0–14 | 13 (1.5) | 33 (3.4) | 0.041 |
15–29 | 110 (12.6) | 135 (14.1) | |
30–44 | 447 (51.4) | 482 (50.2) | |
45 and above | 300 (34.5) | 311 (32.4) | |
Gender | |||
Male | 546 (62.8) | 597 (62.1) | 0.779 |
Female | 324 (37.2) | 364 (37.9) | |
District | |||
Belgaum | 226 (26.0) | 558 (58.1) | < 0.001 |
Gulbarga | 185 (21.7) | 47 (4.9) | |
Bagalkot | 425 (48.9) | 144 (15.0) | |
Bangalore | 34 (3.9) | 212 (22.1) | |
Type of TB | |||
Microbiologically confirmed | 283 (32.5) | 507 (52.8) | <0.001 |
Clinically diagnosed | 587 (67.5) | 454 (47.2) | |
Site of TB | |||
Pulmonary TB | 732 (84.1) | 698 (79.5) | 0.010 |
Extra Pulmonary TB | 138 (15.9) | 156 (20.5) | |
Category of TB Treatment | |||
New | 708 (81.4) | 789 (82.1) | 0.689 |
Previously treated | 162 (18.6) | 172 (17.9) | |
ART status | |||
On ART | 782 (89.9) | 829 (86.3) | 0.017 |
Not on ART | 88 (10.1) | 61 (13.7) | |
CD4 count (cells/mm3) | |||
Less than 50 | 91 (10.5) | 66 (6.9) | <0.001 |
50–199 | 384 (44.1) | 353 (36.7) | |
200–349 | 168 (19.3) | 215 (22.4) | |
350–499 | 83 (9.5) | 94 (9.8) | |
More than 500 | 61 (7.0) | 81 (8.4) | |
Not available | 83 (9.5) | 152 (15.8) | |
CD4 count (Median (IQR)) | 160 (83–280) | 194 (100–315) | 0.001# |
*Column Percentage, †Chi-square test, #Mann Whitney U test
Abbreviations: HIV- Human Immunodeficiency Virus; TB- Tuberculosis; ART- Antiretroviral Therapy; CD4- Cluster of Differentiation 4/CD4 + T helper cells